Insulet (PODD) Shares Outstanding (Diluted Average) (2016 - 2026)
Insulet posted quarterly Shares Outstanding (Diluted Average) of $70.2 million for Q1 2026, down 5.27% year-on-year from $74.1 million in Q1 2025, and down 2.34% on a QoQ basis from $71.9 million in Q4 2025.
Insulet (PODD) has 11 years of Shares Outstanding (Diluted Average) data on file, last reported at $70.2 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 5.27% year-over-year to $70.2 million; the trailing twelve-month figure through Mar 2026 stood at $70.2 million (down 5.27% YoY), and the FY2025 full-year result was $71.9 million, down 2.71% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $70.2 million, down from $71.9 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $74.1 million in Q1 2025 and bottomed at $69.3 million in Q2 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $71.9 million (2025), against an average of $71.8 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) advanced 6.17%; it then slipped 5.27% in 2026.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $69.9 million in 2022, then gained by 5.33% to $73.6 million in 2023, then grew by 0.35% to $73.9 million in 2024, then retreated by 2.71% to $71.9 million in 2025, then decreased by 2.34% to $70.2 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $70.2 million (Q1 2026), $71.9 million (Q4 2025), and $72.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | 70.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.20 Mn |
| Dec 31, 2025 | 71.89 Mn |
| Sep 30, 2025 | 72.29 Mn |
| Jun 30, 2025 | 70.64 Mn |
| Mar 31, 2025 | 74.11 Mn |
| Dec 31, 2024 | 73.89 Mn |
| Sep 30, 2024 | 73.83 Mn |
| Jun 30, 2024 | 73.80 Mn |
| Mar 31, 2024 | 73.74 Mn |
| Dec 31, 2023 | 73.63 Mn |
| Sep 30, 2023 | 73.62 Mn |
| Jun 30, 2023 | 70.12 Mn |
| Mar 31, 2023 | 70.10 Mn |
| Dec 31, 2022 | 69.91 Mn |
| Sep 30, 2022 | 69.34 Mn |
| Jun 30, 2022 | 69.31 Mn |
| Mar 31, 2022 | 69.86 Mn |
| Dec 31, 2021 | 68.58 Mn |
| Sep 30, 2021 | 67.24 Mn |
| Jun 30, 2021 | 66.41 Mn |
| Mar 31, 2021 | 66.11 Mn |
| Dec 31, 2020 | 65.95 Mn |
| Sep 30, 2020 | 66.83 Mn |
| Jun 30, 2020 | 64.97 Mn |
| Mar 31, 2020 | 62.88 Mn |
| Dec 31, 2019 | 62.30 Mn |
| Sep 30, 2019 | 62.34 Mn |
| Jun 30, 2019 | 61.49 Mn |
| Mar 31, 2019 | 61.15 Mn |
| Dec 31, 2018 | 61.01 Mn |
| Sep 30, 2018 | 58.78 Mn |
| Jun 30, 2018 | 58.83 Mn |
| Mar 31, 2018 | 58.48 Mn |
| Dec 31, 2017 | 58.00 Mn |
| Sep 30, 2017 | 58.10 Mn |
| Dec 31, 2016 | 57.25 Mn |